841. Tebipenem pivoxil - Spero Therapeutics
Session: Symposium: Exploring the Antibiotic Pipeline 2018
Thursday, October 4, 2018: 2:30 PM
Room: N Hall D
David Melnick, MD, Spero Therapeutics, Cambridge, MA



Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.